- Up to 15M Johnson & Johnson coronavirus vaccine doses ruined due to human error: NYT (fiercepharma.com)
Workers at an Emergent BioSolutions plant in Baltimore mixed up vaccine ingredients weeks ago and ruined a large batch of the vaccine containing up to 15 million doses...The FDA is investigating the mistake, but the episode has led to a temporary halt of future J&J shot deliveries from the site...In a statement, J&J said it's working with federal authorities to deliver 24 million doses of the vaccine in April...The mistake happened early in the production process, so none of the doses made it out to distribution...READ MORE
- New CDC study: mRNA vaccines 90% effective (msn.com)Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021 (cdc.gov)
In their clinical trials, the Pfizer and Moderna vaccines did okay, well enough for the FDA to grant emergency use authorization. But in a real-world study, where participants were all on the front lines fighting Covid, the vaccines proved 90% effective against the virus – not just the symptomatic disease. In the clinical studies, Pfizer and Moderna were testing against disease...According to the CDC-sponsored study released today, it didn’t matter which vaccine the participants received. What mattered was that both vaccines were designed using messenger RNA to repel the coronavirus. The results showed that the vaccines were even effective against asymptomatic virus...READ MORE
- U.S. to share 4 million doses of AstraZeneca COVID-19 vaccine with Mexico, Canada (reuters.com)
The United States plans to send roughly 4 million doses of AstraZeneca's COVID-19 vaccine that it is not using to Mexico and Canada in loan deals with the two countries, yielding to requests to share vaccines with allies...Mexico will receive 2.5 million doses of the vaccine and Canada is to receive 1.5 million doses...The Biden administration has come under pressure from countries around the world to share vaccines, particularly its stock of AstraZeneca’s vaccine, which is authorized for use elsewhere but not yet in the United States...READ MORE
- Abbott announces its Pandemic Defense Coalition (worldpharmanews.com)
Abbott announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats. By connecting global centers of excellence in laboratory testing, genetic sequencing and public health research, the program will identify new pathogens, analyze potential risk level, rapidly develop and deploy new diagnostic testing and assess public health impact in real time...READ MORE
- Tracking the success of Johns Hopkins’ high-profile COVID-19 website (healthcareitnews.com)Johns Hopkins Coronavirus Resource Center (coronavirus.jhu.edu)
Here's a look at how it was created, what it offers – and how it grew to reach more than 38 million visits in seven months...Amid the COVID-19 pandemic, Johns Hopkins Medicine needed to provide accurate content very quickly in an information environment that was changing by the hour...In a pre-pandemic world, the organization's content team would look to search engine optimization strategies to see what questions people are asking and determine what information would be most useful. However, that data was just not yet available for COVID-19 when the pandemic hit...READ MORE
- AstraZeneca’s COVID-19 vaccine defies data controversy with 76% effectiveness in phase 3 (fiercepharma.com)
AstraZeneca created a COVID-19 vaccine data controversy this week by reportedly selecting the most favorable data to tout on its program, a move independent data monitors publicly flagged in a middle-of-the-night missive. Now, with a speedy data update and analysis, AstraZeneca says it can “confirm” the vaccine’s phase 3 success...In a newly released primary analysis, AstraZeneca says its vaccine was 76% effective against symptomatic COVID-19 and 85% effective against symptomatic disease in people 65 and over. The shot was also 100% effective against severe disease and hospitalization in the phase 3 trial...READ MORE
- Overworked, understaffed: Pharmacists say industry is in crisis, putting patient safety at risk (msn.com)
From the moment Marilyn Jerominski walks into her pharmacy every morning, her time is in demand. As pharmacy manager of a busy 24-hour Walgreens in Palm Desert, California, she is responsible for the safety and accuracy of the thousands of prescriptions the store dispenses every week..."There's so much stress," Jerominski said. "You're not only running to the drive-thru but to the front, to the vaccination station to give a vaccination, then to the phone. ... It's almost impossible for any human to keep that momentum day in and out."...Jerominski is one of an estimated 155,000 pharmacists working at chain drugstores who, over the past decade, have found themselves pushed to do more with less. They're working faster, filling more orders and juggling a wider range of tasks with fewer staff members at a pace that many say is unsustainable and jeopardizes patient safety...READ MORE
- WHO warns about fake COVID-19 vaccines on the dark web (healthcareitnews.com)
Forged vaccination certificates and fake negative tests are also reportedly available for purchase on the black market...The World Health Organization...issued a warning about counterfeit and stolen COVID-19 vaccines being sold on the dark web...Fake vaccination certificates are also being sold, as well as fake negative tests, aimed at those traveling abroad...The WHO is "aware of vaccines being diverted and reintroduced into the supply chain, with no guarantee that [the] cold chain has been maintained...READ MORE
- U.S. health officials raise concerns over AstraZeneca vaccine data (pharmacist.com)AstraZeneca accused of cherry-picking vaccine study data (apnews.com)Missteps could mar long-term credibility of AstraZeneca shot (apnews.com)
In an unusual move... officials with the National Institute of Allergy and Infectious Diseases urged AstraZeneca to ensure it is providing the most recent efficacy data on its coronavirus vaccine. The statement came 1 day after the manufacturer released interim data from its U.S. trials...NIAID...said an independent monitoring board informed it that AstraZeneca's disclosures of the study results may have been based on outdated evidence. The agency's response to the company...READ MORE
- Nevada pharmacies now vaccinating 55+ with health conditions (reviewjournal.com)
People from 55 to 64 with certain medical conditions are now eligible to get COVID-19 vaccinations at Nevada pharmacies, with no proof of medical status required...The state opened up eligibility this week to those in this age group with conditions ranging from cancer to smoking that put them at higher risk for serious disease from COVID-19...Eligibility also has been extended to those with conditions that only potentially put them at higher risk, such as asthma or dementia, as well as to those with disabilities or who are experiencing homelessness...READ MORE